Does EVINACUMAB-DGNB Cause Product dose omission issue? 6 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Product dose omission issue have been filed in association with EVINACUMAB-DGNB. This represents 6.5% of all adverse event reports for EVINACUMAB-DGNB.
6
Reports of Product dose omission issue with EVINACUMAB-DGNB
6.5%
of all EVINACUMAB-DGNB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product dose omission issue From EVINACUMAB-DGNB?
Of the 6 reports.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVINACUMAB-DGNB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does EVINACUMAB-DGNB Cause?
Nausea (14)
Fatigue (12)
Pain (9)
Hepatic steatosis (7)
Diarrhoea (6)
Dizziness (6)
Drug ineffective (6)
International normalised ratio increased (6)
Death (5)
Headache (5)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)